CA
PGEN icon

CoreCap Advisors’s Precigen PGEN Stock Holding History

CoreCap Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85K Hold
500
– – ﹤0.01% 2446
2026
Q1 		$1.94K Hold
500
– – ﹤0.01% 2421
2025
Q4 		$2.09K Hold
500
– – ﹤0.01% 2467
2025
Q3 		$1.65K Hold
500
– – ﹤0.01% 2407
2025
Q2 		$710 Hold
500
– – ﹤0.01% 2469
2025
Q1 		$745 Buy
+500
New +$787 ﹤0.01% 2593

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CoreCap Advisors's PGEN Position: Q2 2026 in Review

CoreCap Advisors held its Precigen (PGEN) position steady in Q2 2026 at 500 shares worth $2.85K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

CoreCap Advisors first reported a position in PGEN in Q1 2025 and has held it in 6 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • CoreCap Advisors held 500 shares of Precigen worth $2.85K as of Q2 2026.
  • CoreCap Advisors left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2446 holding.
  • CoreCap Advisors first reported a position in Precigen in Q1 2025 and has held it in 6 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.